武田是一家致力于研发的全球制药公司,提供以科学为基础的创新药品,为全球患者的健康保驾护航。武田专注于肿瘤、胃肠、中枢神经系统等疾病领域的研究,并在心血管疾病和疫苗的后期研究领域进行多项开发。武田通过内部研发以及外部合作,始终处于创新前沿地位。武田于1994年进入中国。随着中国经济的发展和对医疗保健需求的不断增长,中国已经成为武田全球最重要的新兴市场之一。武田通过扎根中国,更加贴近中国患者和医疗专业市场,从而加快公司在中国的本土化。武田在中国的发展战略是不断加强医学科学专业能力,推出创新药物造福中国患者,成为业界首选合作伙伴,以及重视人才发展。


武田中国总部位于上海,在中国大陆的主要业务中心位于北京、上海、天津和广州等城市,并在全国各主要城市设有办事处。


Takeda Pharmaceutical Company Limited is a global, R&D-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its research efforts on oncology, gastroenterology and central nervous system therapeutic areas. It also has specific development programs in specialty cardiovascular diseases as well as late-stage candidates for vaccines. Takeda conducts R&D both internally and with partners to stay at the leading edge of innovation. Takeda entered China in 1994. With the development of its economy and an ever increasing demand for health care, China has become one of the most important emerging markets in the world for Takeda. Taking hold in China, Takeda has garnered close relationships with the Chinese patients and with the healthcare market, thus accelerating its localization in China. Takeda's development strategy in China is to continually strengthen its professional ability in the field of medical science, to launch innovative drugs to benefit Chinese patients, to attach importance to talent cultivation, and to become the preferred partner in the industry.


The Headquarters of Takeda China is based in Shanghai with its major business centers located in Beijing, Shanghai, Tianjin, and Guangzhou. Takeda also has offices in the major cities in mainland China.

2018年12月03日

泰科电子
渣打银行

上一篇

下一篇

武田

武田